Aphria Inc. (OTCMKTS:APHQF) is a vertically integrated cannabis company based in Leamington, Ontario, Canada. Founded in 2013, the company focuses on the cultivation, processing and distribution of medical and adult-use cannabis products. Aphria operates greenhouse and indoor growing facilities that leverage proprietary growing techniques to produce a range of cannabis varieties, aiming to ensure consistency, quality and cost efficiency across its portfolio.
The company’s product line includes dried flower, cannabis oils, softgel capsules, concentrates and vaporizers, designed to meet both medical patient needs and adult-use consumer preferences. Aphria has developed in-house extraction and formulation capabilities, allowing it to supply high-purity cannabinoid extracts for both retail and pharmaceutical applications. Its research and development efforts have focused on developing new delivery systems and improving cultivation methods to enhance yield and potency.
Aphria maintains a presence in key international markets through partnerships and subsidiaries, exporting medical cannabis products to Europe, Latin America and other regulated jurisdictions. In Europe, it serves patients and distributors in countries such as Germany and Italy, while in Latin America its operations span Colombia, Argentina and Mexico. The company’s global footprint has been strengthened by strategic alliances and joint ventures, aimed at expanding market access and distribution channels in emerging cannabis markets.
Over the years, Aphria has been led by a management team with expertise in agribusiness and consumer packaged goods. Under the leadership of former CEO Vic Neufeld, Aphria grew from a small Canadian start-up into a major global cannabis producer. In May 2021, Aphria completed a merger with Tilray Brands, creating one of the largest global cannabis companies, while continuing to trade on select public markets under its existing ticker for North American investors.
AI Generated. May Contain Errors.